Surgical results of upper thoracic esophageal carcinoma

Journal of the Chinese Medical Association

Volumn 67, Issue 9, 2004, Pages 447-457

  Wang, Hao Wei ^a   Kuo, Kuang Tai ^a   Wu, Yu Chung ^a   Huang, Biing Shiun ^a   Hsu, Wen Hu ^a   Huang, Min Hsiung ^a   Wang, Liang Shun ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Esophageal neoplasm; Esophagectomy; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DATA ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LUNG COMPLICATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 9244236528     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wang LS, Huang MH, Huang BS, Chien KY. Gastric substitution for resectable carcinoma of the esophagus: an analysis of 368 cases. Ann Thorac Surg 1992;53:289-94.
2. Fahn HJ, Wang LS, Huang BS, Huang MH, Chien KY. Tumor recurrence in long-tenn survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 1994;57:677-81.
3. Health Statistics, Department of Health, Executive Yuan, Taiwan. 1981-2002.
4. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996;78:1820-8.
5. Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K. Long-term results of subtotal esophagectomy with 3-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994;219:310-6.
6. Bedard EL, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001;91:2423-30.
7. Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, Huang MH. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 1999;94:1933-40.
8. Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Ishikawa T, Kagami Y. Thoracic esophageal carcinoma above the carina: a more formidable adversary? J Surg Oncol 1997;65:28-33.
9. Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 2003; 238:339-47.
10. Manshanden CG, Hulscher JB, Hovius M, Fockens P, van Lanschot JJ, Obertop H. Limited resection for carcinoma of the upper thoracic oesophagus is not a realistic option. Eur J Surg Oncol 2000;26:561-6.
11. American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 6th ed., Philadelphia: Lippincott-Raven, 2002.
12. Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. J Surg Oncol 1996;62:22-9.
13. Vigneswaran WT, Trastek VF, Pairolero PC, Deschamps C, Daly RC, Allen MS. Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus. J Thorac Cardiovasc Surg 1994;107:901-6.
14. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-44.
15. Osugi H, Takemura M, Takada N, Hirohashi K, Kinoshita H, Higashino M. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 2002;89:909-13.
16. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002;95:1434-43.
17. Christein JD, Hollinger EF, Millikan KW. Prognostic factors associated with resectable carcinoma of the esophagus. Am Surg 2002;68:258-62.
18. Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 2003;238:197-202.
19. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, et al. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 2003;133:486-94.
20. Wang LS, Chow KC, Li WY, Liu CC, Wu YC, Huang MH. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma. Clin Cancer Res 2000;6:1445-51.
21. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225-32.
22. Altorki NK, Migliore M, Skinner DB. Esophageal carcinoma with airway invasion: evolution and choices of therapy. Chest 1994;106:742-5.
23. Matsubara T, Ueda M, Nakajima T, Nakagawa K, Yamashita T, Horikoshi N, Yanagisawa A. Can esophagectomy cure cancer of the thoracic esophagus involving the major airways? Ann Thorac Surg 1995;59:173-7.
24. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73: 1779-84.
25. Urba SG, Orringer MB, Perez-Tamayo C, Bromberg J, Forastiere A. Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma. Cancer 1992;69:285-91.
26. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-7.
27. Tsujinaka T, Shiozaki H, Yamamoto M, Inoue M, Yano M, Doki Y, Monden M. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg 1999;177:503-6.
28. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003;21:4592-6.